Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00957 |
| Species: | Homo sapiens |
| Position : | chr8:140948000-140952000 |
| Year: | 2014 |
| Title: | The PEG13-DMR and brain-specific enhancers dictate imprinted expression within the 8q24 intellectual disability risk locus |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | medulloblastoma |
| PMID: | 24667089 |
| MONDO: | MONDO:0005146 |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | HD-MB03 |
| CVCL ID: | CVCL_IT11 |
| Cell Type: | medulloblastoma cell |
| Cell Ontology ID: | CL:0000127 |
| Experiment Type: | Chromatin interaction assay |
| High Throughput Method: | ChIA-PET |
| Low Throughput Method: | 3C-RT-qPCR, Allele-specific RT-PCR, RT-RT-qPCR |
| Target gene : | KCNK9 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|